• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症、轻度认知障碍(MCI)和主观认知下降(SCD)患者预期寿命的性别差异。

Sex differences in life expectancy in dementia, mild cognitive impairment (MCI), and subjective cognitive decline (SCD).

作者信息

Amland Rachel, Selbæk Geir, Brækhus Anne, Rhodius-Meester Hanneke F M, Strand Bjørn H

机构信息

The Norwegian National Centre for Ageing and Health Vestfold Hospital Trust Tønsberg Norway.

Department of Geriatric Medicine Oslo University Hospital Oslo Norway.

出版信息

Alzheimers Dement (Amst). 2025 Sep 15;17(3):e70177. doi: 10.1002/dad2.70177. eCollection 2025 Jul-Sep.

DOI:10.1002/dad2.70177
PMID:40959580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12434703/
Abstract

INTRODUCTION

It is unclear how dementia affects loss in life expectancy (LE). In this registry-based study, we aimed to study sex differences in LE and loss in LE in dementia, mild cognitive impairment (MCI), and subjective cognitive decline (SCD).

METHODS

A total of 16,358 patients diagnosed with dementia, MCI, or SCD from the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) during 2009-2022 were included and followed up for mortality. Sex differences in LE and loss in LE were predicted using flexible parametric survival models and sex-specific mortality in the general population as reference.

RESULTS

Among dementia patients, women with dementia had the largest loss in LE: 17 years loss at 60 years; correspondingly, men lost 13.5 years. Similar patterns were observed for MCI and dementia subtypes.

DISCUSSION

Women with dementia or MCI had a larger loss in LE compared to men with these diagnoses.

HIGHLIGHTS

Women with dementia had the largest loss in life expectancy compared to the general population.The excess female loss in life expectancy was also evident for all the dementia subtypes and for mild cognitive impairment.The loss in life expectancy was more pronounced in younger patients with dementia, with a loss of 17 years in women at 60 years of age. Men, in comparison, lost 13.5 years at the same age.Subjective cognitive decline was associated with a minor loss in life expectancy in both sexes.

摘要

引言

目前尚不清楚痴呆症如何影响预期寿命(LE)的缩短。在这项基于登记处的研究中,我们旨在研究痴呆症、轻度认知障碍(MCI)和主观认知衰退(SCD)患者在预期寿命和预期寿命缩短方面的性别差异。

方法

纳入了2009年至2022年期间从挪威认知症状评估登记处(NorCog)诊断为痴呆症、MCI或SCD的16358名患者,并对其进行死亡率随访。使用灵活的参数生存模型预测预期寿命和预期寿命缩短方面的性别差异,并以一般人群中特定性别的死亡率作为参考。

结果

在痴呆症患者中,患有痴呆症的女性预期寿命缩短最多:60岁时缩短17年;相应地,男性缩短13.5年。在MCI和痴呆症亚型中也观察到类似模式。

讨论

与患有这些疾病的男性相比,患有痴呆症或MCI的女性预期寿命缩短更多。

要点

与一般人群相比,患有痴呆症的女性预期寿命缩短最多。在所有痴呆症亚型和轻度认知障碍中,女性预期寿命的额外缩短也很明显。在较年轻的痴呆症患者中,预期寿命缩短更为明显,60岁的女性缩短17年。相比之下,同龄男性缩短13.5年。主观认知衰退与两性预期寿命的轻微缩短有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/ff40456e2fb5/DAD2-17-e70177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/b12f18a41b07/DAD2-17-e70177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/2998d40bfe80/DAD2-17-e70177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/ff40456e2fb5/DAD2-17-e70177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/b12f18a41b07/DAD2-17-e70177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/2998d40bfe80/DAD2-17-e70177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3970/12434703/ff40456e2fb5/DAD2-17-e70177-g003.jpg

相似文献

1
Sex differences in life expectancy in dementia, mild cognitive impairment (MCI), and subjective cognitive decline (SCD).痴呆症、轻度认知障碍(MCI)和主观认知下降(SCD)患者预期寿命的性别差异。
Alzheimers Dement (Amst). 2025 Sep 15;17(3):e70177. doi: 10.1002/dad2.70177. eCollection 2025 Jul-Sep.
2
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
5
Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment.主观认知衰退加和纵向评估与认知障碍风险。
JAMA Psychiatry. 2024 Oct 1;81(10):993-1002. doi: 10.1001/jamapsychiatry.2024.1678.
6
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
7
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
8
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
9
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
10
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.

本文引用的文献

1
Time to nursing home admission and death in people with dementia: systematic review and meta-analysis.痴呆症患者入住养老院及死亡的时间:系统评价与荟萃分析。
BMJ. 2025 Jan 8;388:e080636. doi: 10.1136/bmj-2024-080636.
2
Dementia, survival rates, and nursing home admissions.
BMJ. 2025 Jan 8;388:q2677. doi: 10.1136/bmj.q2677.
3
Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.预测伴有轻度认知障碍或轻度痴呆的淀粉样蛋白阳性患者的认知能力下降。
Neurology. 2024 Aug 13;103(3):e209605. doi: 10.1212/WNL.0000000000209605. Epub 2024 Jul 10.
4
Machine learning algorithms for identifying predictive variables of mortality risk following dementia diagnosis: a longitudinal cohort study.机器学习算法在识别痴呆症诊断后死亡风险预测变量中的应用:一项纵向队列研究。
Sci Rep. 2023 Jun 10;13(1):9480. doi: 10.1038/s41598-023-36362-3.
5
Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.阿尔茨海默病、帕金森病和肌萎缩侧索硬化症中的性别差异:叙事性综述。
Mech Ageing Dev. 2023 Jun;212:111821. doi: 10.1016/j.mad.2023.111821. Epub 2023 Apr 29.
6
Sex Differences in Alzheimer's Disease.阿尔茨海默病的性别差异。
Neurol Clin. 2023 May;41(2):343-358. doi: 10.1016/j.ncl.2023.01.001.
7
Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy.具有边缘优势型与年龄相关 TDP-43 脑病的患者的认知和临床特征。
Neurology. 2023 May 9;100(19):e2027-e2035. doi: 10.1212/WNL.0000000000207159. Epub 2023 Mar 20.
8
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
9
Normative Scores on the Norwegian Version of the Mini-Mental State Examination.挪威版简易精神状态检查表的常模分数。
J Alzheimers Dis. 2023;92(3):831-842. doi: 10.3233/JAD-221068.
10
Dementia research needs a global approach.痴呆症研究需要全球协作的方法。
Nat Med. 2023 Feb;29(2):279. doi: 10.1038/s41591-023-02249-z.